Taher A Salaheldin (Taher Salaheldin)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Staphylococcus Aureus

Top Venues

Nanomedicine (London, England)

International journal of nanomedicine

This page only lists publications with an associated author ORCID identifier.

Publications

Thangirala Sudha, Taher A Salaheldin, Noureldien He Darwish, Shaker A Mousa
Antitumor/anti-angiogenesis efficacy of epigallocatechin gallate nanoformulated with antioxidant in melanoma. Nanomedicine (London, England) 17 (15) (2022)
Ozlem Ozen Karakus, Kavitha Godugu, Taher A Salaheldin, Kazutoshi Fujioka, Shaker A Mousa
Norepinephrine transporter analog benzylguanidine-conjugated nanoparticles for the delivery of paclitaxel in neuroblastoma. Nanomedicine (London, England) 16 (26) (2021)
Samar A Salim, Elbadawy A Kamoun, Stephen Evans, Shahira Hussainy El-Moslamy, Esmail M El-Fakharany, Mohamed M Elmazar, A F Abdel-Aziz, Radwa H Abou-Saleh, Taher A Salaheldin
Mercaptopurine-Loaded Sandwiched Tri-Layered Composed of Electrospun Polycaprolactone/Poly(Methyl Methacrylate) Nanofibrous Scaffolds as Anticancer Carrier with Antimicrobial and Antibiotic Features: Sandwich Configuration Nanofibers, Release Study and in vitro Bioevaluation Tests. International journal of nanomedicine 16 (2021)
Ali H El-Far, Taher A Salaheldin, Kavitha Godugu, Noureldien H E Darwish, Shaker A Mousa
Thymoquinone and its nanoformulation attenuate colorectal and breast cancers and alleviate doxorubicin-induced cardiotoxicity. Nanomedicine (London, England) (2021)